United States Securities and Exchange Commission · EDGAR Accession 0001213900-25-094692

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 1797565
Period 2024-12-31

BioPact Cellular Transport, Inc.

CorporationNVIncorporated 2019Austin, TXbiopactct.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 3152%2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(163,296)(368,065)▲ burn
Total assets19,70519,070▲ 3%
Cash & equivalents9,6156,738▲ 43%
Accounts receivable00
Short-term debt621,138507,629▲ 22%
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.